These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 2133985)

  • 1. Topical corticosteroid therapy in psoriasis vulgaris.
    Trozak DJ
    Cutis; 1990 Oct; 46(4):341-50. PubMed ID: 2133985
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A trial of the Actiderm dermatological patch and topical corticosteroids in the treatment of psoriasis vulgaris. The Actiderm Multi-Center Study Group.
    Cutis; 1990 Jul; 46(1):84-8. PubMed ID: 2200652
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Factors impacting the combination of topical corticosteroid therapies for psoriasis: perspectives from the International Psoriasis Council.
    van de Kerkhof PC; Kragballe K; Segaert S; Lebwohl M;
    J Eur Acad Dermatol Venereol; 2011 Oct; 25(10):1130-9. PubMed ID: 21564329
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Are ointments better than other vehicles for corticosteroid treatment of psoriasis?
    Zivkovich AH; Feldman SR
    J Drugs Dermatol; 2009 Jun; 8(6):570-2. PubMed ID: 19537382
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Topical corticosteroids in psoriasis: strategies for improving safety.
    Horn EJ; Domm S; Katz HI; Lebwohl M; Mrowietz U; Kragballe K;
    J Eur Acad Dermatol Venereol; 2010 Feb; 24(2):119-24. PubMed ID: 20175860
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Topical corticosteroid treatment: its significance and limitation].
    Ishihara M
    Horumon To Rinsho; 1971 Feb; 19(2):96-102. PubMed ID: 5101982
    [No Abstract]   [Full Text] [Related]  

  • 7. Corticosteroids: options in the era of steroid-sparing therapy.
    Del Rosso J; Friedlander SF
    J Am Acad Dermatol; 2005 Jul; 53(1 Suppl 1):S50-8. PubMed ID: 15968264
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Current status of external corticosteroid therapy].
    Gloor M
    Fortschr Med; 1985 Feb; 103(5):82-6. PubMed ID: 3156081
    [No Abstract]   [Full Text] [Related]  

  • 9. Treatment of psoriasis with topically applied tretinoin and steroid ointment.
    Kaidbey KH; Petrozzi JW; Kligman AM
    Arch Dermatol; 1975 Aug; 111(8):1001-3. PubMed ID: 786170
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increasing use of non-traditional vehicles for psoriasis and other inflammatory skin conditions.
    Huang KE; Davis SA; Cantrell J; Feldman SR
    Dermatol Online J; 2014 Sep; 20(9):. PubMed ID: 25244174
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Topical management of psoriasis - corticosteroids and sparing corticosteroid therapy.
    Gorgievska Sukarovska B; Lipozencić J
    Acta Dermatovenerol Croat; 2006; 14(3):188-96. PubMed ID: 17010269
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New developments in topical sequential therapy for psoriasis.
    Koo JY
    Skin Therapy Lett; 2005 Nov; 10(9):1-4. PubMed ID: 16292458
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drug delivery and formulations for the topical treatment of psoriasis.
    Su YH; Fang JY
    Expert Opin Drug Deliv; 2008 Feb; 5(2):235-49. PubMed ID: 18248321
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Erythrodermal pustular psoriasis: adrenal inertia after local corticoid therapy under occlusive dressings].
    Thiers H; Moulin G; Gharib C
    Bull Soc Fr Dermatol Syphiligr; 1967; 74(3):370-1. PubMed ID: 6064316
    [No Abstract]   [Full Text] [Related]  

  • 15. Strategies to optimize efficacy, duration of remission, and safety in the treatment of plaque psoriasis by using tazarotene in combination with a corticosteroid.
    Lebwohl M
    J Am Acad Dermatol; 2000 Aug; 43(2 Pt 3):S43-6. PubMed ID: 10898829
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Factors affecting prescription of ultra-high potency topical corticosteroids in skin disease: an analysis of US national practice data.
    Balkrishnan R; Camacho FT; Pearce DJ; Kulkarni AS; Spencer L; Fleischer AB; Feldman SR
    J Drugs Dermatol; 2005; 4(6):699-706. PubMed ID: 16302555
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The evolving role of therapeutic shampoos for targeting symptoms of inflammatory scalp disorders.
    Kircik L
    J Drugs Dermatol; 2010 Jan; 9(1):41-8. PubMed ID: 20120424
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A guide to topical corticosteroids.
    Goldman L
    Am Fam Physician; 1973 Sep; 8(3):167-70. PubMed ID: 4729714
    [No Abstract]   [Full Text] [Related]  

  • 19. Treatment of psoriasis and other dermatoses with a single application of a corticosteroid left under a hydrocolloid occlusive dressing for one week.
    Juhlin L
    Acta Derm Venereol; 1989; 69(4):355-7. PubMed ID: 2568063
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effect of vitamin A acid (VAA) on psoriasis. Topical combined therapy using corticoids. Two new VAA preparations for oral administration].
    Orfanos CE; Schmidt HW; Mahrle G; Runne U
    Arch Dermatol Forsch; 1972; 244():424-6. PubMed ID: 4648740
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.